-transparent.png){kind=logo}
Endogenous and exogenous opiate-like compounds have been found to cause increased serum growth hormone and prolactin levels in animals, and, in some cases, humans. Naloxone, a relatively specific narcotic antagonist, decreases serum prolactin and growth hormone levels in animals. Naloxone (20 mg IV) did not significantly alter serum prolactin levels and, minimally but not significantly, increased growth hormone levels in humans to whom it was administered.
Related Publications
D Janowsky, and
L Judd, and
L Huey, and
N Roitman, and
D Parker
October 1975,
The Journal of clinical endocrinology and metabolism,
D Janowsky, and
L Judd, and
L Huey, and
N Roitman, and
D Parker
May 1980,
The Journal of endocrinology,
D Janowsky, and
L Judd, and
L Huey, and
N Roitman, and
D Parker
August 1977,
Life sciences,
D Janowsky, and
L Judd, and
L Huey, and
N Roitman, and
D Parker
July 1965,
Zeitschrift fur arztliche Fortbildung (Berlin),
D Janowsky, and
L Judd, and
L Huey, and
N Roitman, and
D Parker
May 1976,
The Journal of clinical endocrinology and metabolism,
D Janowsky, and
L Judd, and
L Huey, and
N Roitman, and
D Parker
February 1979,
Acta psychiatrica Scandinavica,
D Janowsky, and
L Judd, and
L Huey, and
N Roitman, and
D Parker
January 1986,
Psychopharmacology,
D Janowsky, and
L Judd, and
L Huey, and
N Roitman, and
D Parker
July 1982,
Acta endocrinologica,
D Janowsky, and
L Judd, and
L Huey, and
N Roitman, and
D Parker
August 1980,
The Journal of clinical endocrinology and metabolism,
D Janowsky, and
L Judd, and
L Huey, and
N Roitman, and
D Parker
August 1985,
The Journal of clinical endocrinology and metabolism,
